JH

Jonathan Hepple

Founder & Director at Rosetta Capital

London, UK

About

Jonathan Hepple is the current Non-Executive Director of Nucleome Therapeutics. He previously worked at BioScience Managers Limited as a Founder and Director. Jonathan attended the University of Cambridge.

Position in the VCSift Database

  • 56 investors hold the Founder & Director role in VCSift. Jonathan Hepple is one of them.
  • 8,972 investors are based in London, England, United Kingdom.

Data sourced from 410,343 investor profiles. Updated July 2026.

Investment Focus

Location
London, UK

Contact Information

em••••@example.com
linkedin.com/in/••••••••

Unlock contact details with a VCSift subscription

Unlock Contact

Already subscribed? Log in

Find more investors like Jonathan

Search Investors